The World Health Organization is calling on drug companies to donate more medicine to help to eradicate tropical diseases. One billion people in the world's poorest countries are chronically ill from these diseases, which receive little attention from drug manufacturers and health organizations. Peter Hotez, M.D., Ph.D., GW Distinguished Research Professor and chair of the Department of Microbiology, Immunology, and Tropical Medicine, says that many of these diseases can be treated with a single pill, but there is often no funding for proven and inexpensive treatments.
WHO Outlines Strategy to Combat Neglected Tropical Diseases
Latest News
Basil Considine, a third-year medical student at the George Washington University School of Medicine and Health Sciences (GW SMHS), addressed U.S. Food and Drug Administration (FDA) leadership, pharmaceutical representatives, and association stakeholders during a public meeting regarding the…
The George Washington University School of Medicine and Health Sciences (SMHS) recently honored a pair of accomplished faculty members, Sharad Goyal, MD, and Christina M. Puchalski, MD ’94, RESD ’97, for their academic excellence and leadership in patient care by formally bestowing them with…
The GW Department of Dermatology has been awarded a prestigious Competitive Clinical Research Grant by Eli Lilly and Company to evaluate the effectiveness of Atopic Triad (atopic dermatitis, asthma, and seasonal allergies) screening and education to reduce the burden of Atopic Dermatitis and its…